The Effect of Singing or Playing Melodica in COPD Patients
- Conditions
- Chronic Obstructive Pulmonary Disease
- Registration Number
- NCT05168241
- Lead Sponsor
- Karadeniz Technical University
- Brief Summary
This study was conducted as a randomized controlled experimental study to determine the effect of singing or playing melodica activity applied to chronic obstructive pulmonary patients on symptoms, self-efficacy level, and exercise capacity of patients.
- Detailed Description
The research was carried out in the chest diseases polyclinics of a hospital in Trabzon city center between September 2020 and August 2021 with 30 patients: 15 in the control group and 15 in the song/melodica group. Based on Pender's health promotion model, the control group received training and counseling for ten weeks, including face-toface training and telephone follow-up. According to Pender's health promotion model, patients in the song/melodica group were given face-to-face training once, singing/playing the melodica training twice, and counseling and follow-up over the phone twice, with 15- day intervals. The data were collected with a patient information form and scales examining disease symptoms, self-efficacy, and exercise capacity. To evaluate the data, ttest, Mann-Whitney U, ANOVA, Kruskal Wallis test were used for independent groups to evaluate changes over time, and paired two-sample t-test, Wilcoxon test, and ANOVA test were used in repetitive measurements for dependent groups.
.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- 18 years and older,
- Having been diagnosed with COPD by the physician based on the results of the pulmonary function test taken with spirometry according to the GOLD criteria, who are in the stable period of COPD,
- Applying to thoracic polyclinics,
- not bedridden,
- Does not have vision and hearing problems that do not interfere with communication,
- Patients who can complete the six-minute walk test,
- Willing to sing and/or play melodica
- Patients who agreed to participate in the study and who read and signed the informed consent form were included in the sample.
- Those who do not agree to participate in the research,
- with asthma,
- with a diagnosis of cancer,
- with a diagnosis of Covid-19,
- Having unstable angina or myocardial infarction in the last 1 month,
- Having a resting heart rate >120/min,
- Patients with a resting systolic blood pressure of >180 mmHg and a diastolic blood pressure of >100 mmHg (183) were excluded from the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Modifiye Medical Research Council (mMMC) Dyspnea scale 10 weeks Dyspnea scores of the patients were recorded in the pre-test and post-test.The Medical Research Council Scale (mMRC) consists of five items based on various physical activities that cause dyspnea.
On this scale, patients are asked to simply select the activity that produces the feeling of dyspnea. Scoring is between 0-4. Minimum, maximum, median and mean values were evaluated for each group and compared between groups.
- Secondary Outcome Measures
Name Time Method COPD Assessment Test (CAT) 10 weeks The CAT scale, which rates the effects of chronic obstructive pulmonary disease on the patient and deterioration in health, consists of eight parameters that question "cough, sputum, chest symptoms, fatigue, and confidence in leaving home".
The score that can be obtained from the scale is a minimum of 0 and a maximum of 40 points. CAT scores of the patients were recorded in the pre-test and post-test. Minimum, maximum, median and mean values were evaluated for each group and compared between groups.
Trial Locations
- Locations (1)
Karadeniz Technical University
🇹🇷Trabzon, Turkey
Karadeniz Technical University🇹🇷Trabzon, Turkey